Author

D. Vosoughi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1

Frequent Co-Authors

A. Andreazza· 1 shared A. Baker· 1 shared A. Ohsumi· 1 shared A. Pierro· 1 shared A. Takahagi· 1 shared B. Joe· 1 shared B. Li· 1 shared C. C. dos Santos· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. Andreazza

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Heart-on-a-chip model of immune-induced cardiac dysfunction reveals the involvement of free mitochondrial DNA and therapeutic effects of endothelial exosomes

X. Z. Lu, N. Rafatian, Y. Zhao, K. T. Wagner, E. L. Beroncal, B. Li, C. Lee, J. Chen, E. Churcher, D. Vosoughi, Y. Wang, A. Baker, U. Trahtemberg, B. Li, A. Pierro, , M. Radisic

This paper develops a heart-on-a-chip model to study immune-induced cardiac dysfunction, identifying mitochondrial DNA as a key factor and showing therapeutic potential of endothelial exosomes.

bioRxiv · Aug 9, 2023 · PreprintBioengineering

Ex vivo delivery of regulatory T cells for control of alloimmune priming in the donor lung

E. Miyamoto, A. Takahagi, A. Ohsumi, T. Martinu, D. Hwang, K. Boonstra, B. Joe, M. Juan Umana, K. Bei, D. Vosoughi, M. Liu, M. Cypel, S. Keshavjee, S. C. Juvet

This study shows that ex vivo delivery of regulatory T cells to donor lungs before transplantation can suppress alloimmune responses and improve lung graft outcomes in a rat model.

bioRxiv · Feb 7, 2021Immunology